Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jillian Boice"'
Autor:
Kai Song, Oh Kyu Yoon, Luting Zhuo, Emon Elboudwarej, Biao Li, Jillian Boice, Yang Pan, See Phan, Monica Motwani
Publikováno v:
Cancer Research. 83:4392-4392
Background: Antibody-drug conjugates (ADCs) are novel agents linking potent payloads to antibodies targeting antigen-expressing tumors. Sacituzumab govitecan (SG), a Trop-2-directed ADC, is approved for patients with metastatic triple-negative breast
Autor:
Hiba Graham, Terri Wrin, Joshua C. Cyktor, Michael F. Para, Gregory M. Laird, Heena Patel, Jillian Boice, Rita Humeniuk, Jeffrey Wallin, Romas Geleziunas, Cynthia Brinson, Dianna Koontz, Diana M. Brainard, John W. Mellors, Jana L. Jacobs, Constance A. Benson, Polina German, Susan Guo, Sharon A. Riddler, Rebecca Begley, Moti Ramgopal, Devi SenGupta, Edwin DeJesus, Liao Zhang, Anthony Mills
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 72(11)
Background Treatment with vesatolimod, an investigational, oral, toll-like receptor 7 (TLR7) agonist, leads to sustained viral remission in some non-human primates when combined with anti-envelope antibodies or therapeutic vaccines. We report results
Autor:
Johanna C. Bendell, Ghassan K. Abou-Alfa, Michael A. Morse, Yoon-Koo Kang, Masatoshi Kudo, Joyce Antal, Ann-Lii Cheng, Feng Xiao, Stephen L. Chan, Andrew X. Zhu, Richard D. Kim, Bruno Sangro, Jillian Boice, Shannon R. Morris
Publikováno v:
Journal of Clinical Oncology. 34:TPS3103-TPS3103
TPS3103Background: No approved standard-of-care treatment options exist for patients with unresectable HCC who progress on, are intolerant to, or have refused sorafenib therapy. The PD-1/PD-L1 path...